Study finds no evidence cannabis helps anxiety, depression, or PTSD

Original Article ↗ Hacker News Discussion ↗

Study Design, Scope, and Interpretation

  • Thread centers on a Lancet meta-analysis of 54 RCTs (1980–2025) on cannabinoids and mental disorders.
  • Several commenters say the article headline overreaches: many outcomes are “insufficient evidence” or statistically inconclusive, not “proven ineffective.”
  • Some note the data are heterogeneous with wide confidence intervals, small samples (e.g., ~50 people across six anxiety trials), and many trials rated high risk of bias.
  • Others argue that when error bars are large and harms clearer than benefits, the responsible stance is “don’t recommend for treatment yet.”

Is the Research Studying “Real” Cannabis?

  • Critics say many trials use THC/CBD isolates, non-representative products, or restricted chemovars due to legal constraints, undermining relevance to real-world “full-spectrum” cannabis.
  • Defenders respond that isolates and standardized products are necessary for controlled dosing and that “entourage effect” arguments risk endless goalpost-shifting.
  • Disagreement over how much strain/terpene variation must be explored before drawing practical conclusions.

Efficacy vs. Symptom Relief

  • Multiple commenters stress the difference between:
    • short-term mood/anxiety relief (intoxication, sedation, distraction), and
    • long-term treatment that shifts baseline symptoms.
  • Parallels drawn with alcohol, opioids, stimulants, ketamine, and psychedelics: many feel good acutely but may not improve, or may worsen, chronic conditions.
  • Some note the paper did find tentative evidence for benefits in conditions like insomnia, tics/Tourette, autism spectrum disorder, and cannabis use disorder itself.

Self-Medication, Dependency, and Harms

  • Several report patterns: initial anxiety or depression relief, then tolerance, psychological dependence, rebound anxiety, sleep disruption, or cognitive dulling.
  • Others say cannabis meaningfully reduces chronic pain, anger, or sleep problems with fewer side effects than their alternatives.
  • Concerns raised about psychosis risk, cannabis use disorder, and REM/sleep architecture, though details remain debated and partly unclear.

Legalization, Culture, and Framing

  • Many support legalization while viewing cannabis as a vice or coping tool, not a psychiatric medication.
  • Some criticize decades of pro-weed hype and “cure-all” marketing; others criticize past prohibitionist exaggerations.
  • Broader frustration appears around how medical journals, media headlines, and advocacy on both sides oversimplify nuanced, low-certainty evidence.